Gilead Sciences Acquires Arresto Biosciences for $225,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=718e54ad-59f8-473b-8058-ed212e98753f&Preview=1 -
Date
12/20/2010 -
Company Name
Arresto Biosciences -
Mailing Address
3183 Porter Drive Palo Alto, CA 94304 -
Company Description
Arresto BiosciencesTM is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. -
Website
http://www.arresto.com -
Transaction Type
M&A -
Transaction Amount
$225,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Undisclosed
